Answers are grounded in this paper and cite their sources.
This article provides an introduction to the symposium on best practices for using revealed preference methods for nonmarket valuation. Nonmarket valuation is an essential tool in the benefit–cost analysis (BCA) of environmental goods and services. Here, we identify the role of BCA in several key U.S. Executive Orders, U.K. appraisals, and European Union Directives that inform decision-making concerning regulatory oversight. We describe the evolution of key mandates over the last three decades and discuss some examples of how the analyses performed under these mandates have impacted regulatory outcomes.
No takes yet. Share an insight, caveat, or question.
Bateman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: